Patients with high expression of PTTG1 were associated with poor overall survival (OS) in ACC, KIRC, KIRP, lower grade glioma (LGG), LIHC, LUAD, mesothelioma (MESO), PAAD, THCA, and uveal melanoma (UVM) (Figure 5A, all p < 0.05). Here, PTTG1 is linked to uveal melanoma.